Direct oral anticoagulant secondary prophylaxis vs Low molecular weight heparin secondary prophylaxis
Recurrent VTE · patients with cancer with venous thromboembolism
Direct oral anticoagulant secondary prophylaxis may leads to lower recurrent VTE compared with low molecular weight heparin secondary prophylaxis (low certainty).
1 finding from 1 review
- Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer 2018 · Cochrane Headline outcomes onlyRR 0.63 [0.45, 0.88]5 studies · 2854 participantsLow